An enzymatic assay system for D-Asp was established using D-aspartate oxidase and oxaloacetate decarboxylase. In this system, D-Asp is converted to pyruvate, which is determined fluorometrically with 1,2-diamino-4,5-methylenedioxybenzene. This method makes possible D-Asp measurement at the micromolar level. The D-Asp contents of an edible brown alga, Hijika fusiforme, a lactic acid bacteria beverage, and pig testis were determined by the method.
Some D-amino acids have significant physiological effects not only in bacteria but also in eukaryotes, including mammals. In mammals, D-Asp has been found to be localized primarily in endocrine tissues such as the pineal gland, pituitary gland, and testis, 1) and has been found to have important functions in certain physiological events in certain organs. For instance, it is involved in cerebral hormone secretion in the mammalian brain. 2) In the genital tract, it is probably related to fertilization processes, 3) and is involved in the acceleration of testosterone synthesis in the testis. 4) A variety of foods have been reported to contain significant amounts of D-amino acids. 5, 6) This suggests that people ingest considerable amounts of D-amino acids in daily life, and thus, it is interesting to determine whether they exert their physiological functions in vivo following oral administration. Indeed, several recent reports have suggested that orally administered D-amino acids do have various nutritional and medicinal effects. 7) For example, oral administration of D-Asp has been found to result in increased D-Asp concentrations in rabbit seminal plasma, and in enhanced spermatozoa motility. 8) Since these results do not rule out the possibility that D-Asp in foods affects physiological conditions, the development of a rapid and simple method to assay D-Asp would be useful to study its presence in food as well as its effects on intravital behavior. D-Amino acids are generally assayed by high-performance liquid chromatography (HPLC) after derivatization to fluorescent diastereomers. While this conventional method is sensitive, it is also time-consuming and unsuitable for the analysis of large samples. To address this, Mutaguchi et al. recently developed an enzymatic Asp quantification method by rate assay measurement. It was successfully used to measure L-and D-Asp contents in mouse testes. 9) However, while their method was able to quantify L-and D-Asp rapidly and accurately, difficulties were encountered during simultaneous measurement of multiple samples using standard spectrophotometers. In this study, we developed a novel endpoint D-Asp quantification method using D-aspartate oxidase (DDO, EC 1.4.3.1) from Cryptococcus humicolus.
10)
Quantitative determination of D-Asp with DDO has been done in the DDO assay. 11) In this method, oxaloacetic acid formed from D-Asp after DDO reaction is reacted with 2,4-dinitrophenylhydrazine and the increase in absorption at 445 nm caused by the formation of the keto acid adduct is determined spectrophotometrically, 12) but the sensitivity of the method is not sufficiently high for assay of the D-Asp of various biological samples. Hence we constructed a more sensitive D-Asp assay system by detecting the keto acid fluorophotometrically. The principle is as follows: First DDO converts D-Asp to oxaloacetic acid, which is then converted to pyruvic acid by oxaloacetate decarboxylase (OAD, EC 4.1.1.3, purchased from Asahi kasei pharma (Tokyo, Japan)) from Pseudomonas sp. The pyruvic acid is reacted with 1,2-diamino-4,5-methylenedioxybenzene (DMB), an -keto acid-specific labeling reagent, and the fluorescence intensity of the resulting compound is measured by spectrofluorophotometer. The formation of this fluorescent compound makes possible the measurement of D-Asp at the micromolar level.
13) While DMB reacts with oxaloacetic acid as well as pyruvic acid, their respective fluorescent derivatives show different fluorescent intensities. Because oxaloacetic acid is apt to be non-enzymatically decarboxylated to form pyruvic acid, we used OAD for complete conversion of oxaloacetic acid to pyruvic acid to obtain accurate measurements.
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C. This means that if the sample used for the D-Asp assay contains amino acids besides D-Asp, they are converted to -keto acid during the DMB reaction, thus affecting the measurements. After several trials under varying conditions such as temperature and time, we found that DMB reaction conditions 50 C for 4 h made possible the complete reaction with -keto acids without deamination of other amino acids. As shown in Fig. 1 , the labeling reaction with pyruvic acid (10 mM) reached a plateau after 3-4 h of incubation at 50 C, suggesting that the DMB reaction with pyruvic acid was completed under these conditions. No nonenzymatic deaminations of amino acids occurred: the fluorescence intensity (9:44 AE 2:33, arbitrary unit) of the DMB reaction mixture containing 1 mM each standard L-amino acid and glycine was not higher than that (11:9 AE 1:29) of the DMB reaction mixture containing water instead of amino acids.
In our newly developed assay system for D-Asp, DDO from C. humicolus was used as catalyst because of its high specificity toward D-Asp, 10) but two problems arose during the construction of the assay system. First, DDO possesses FAD as a cofactor, 10) and this was liberated from the enzyme when DDO was denatured to terminate the reaction. This liberated FAD was found to decrease the fluorescence intensity of the product of the subsequent DMB reaction (data not shown). Considering that the peak excitation wavelength of FAD is about 450 nm, this phenomenon might be due either to fluorescence energy transfer from the fluorescent compound to FAD or to the absorption of fluorescence energy by FAD. To avoid the liberation of FAD from DDO, DDO was immobilized with sodium alginate, which allowed DDO to be removed from the reaction mixture without denaturation. Although the specific activity of the immobilized DDO was about one-tenth of that of free DDO, the immobilized DDO can be used to practical effect in our assay system.
Another problem that arose due to the use of DDO is that DDO reacts not only, C, an equal volume of 3 M Bis-Tris buffer (pH 7.0) was added, and the resulting fluorescence intensity was measured using a spectrofluorophotometer (excitation, 367 nm; emission, 444 nm). The accuracy of the D-Asp assay method was examined by obtaining the calibration curve of authentic D-Asp by plotting the fluorescent intensity versus the concentration of D-Asp. The fluorescence intensity increased linearly with increasing D-Asp concentrations from 1 to 50 mM (Fig. 2) , suggesting that D-Asp can be quantified at the micromolar level under these conditions. The slope of the calibration curve of D-Asp was in good agreement with those of oxaloacetic acid and pyruvic acid (data not shown).
To estimate the validity of our newly described enzymatic assay, the D-Asp contents of hijiki, a lactic acid bacteria beverage, and pig testis were analyzed by this method and compared to the values obtained by the conventional HPLC method 13) ( Table 1 ). The D-Asp contents of hijiki, the lactic acid bacteria beverage, and The conventional HPLC method is very sensitive and has the advantage of being able to determine the concentrations of multiple D-and L-amino acids, but is not suitable for assay of large samples simultaneously. Our enzymatic D-Asp assay method requires a fairly long time for the DMB reaction, because the reaction is done at low temperature to avoid non-enzymatic deamination of the amino acids contaminating the samples, but we can assay a number of samples at one time. Our enzymatic assay system addresses the problem of the HPLC assay. While the D-Asp content of various biological samples has been reported to be fairly low, ranging from 1 to 100 nmol/g tissue, 9, 14, 15) our method can detect D-Asp at the micromolar level. This suggests that the enzymatic assay described here has potential application as an assay for D-Asp in biological samples.
